Aspirin Use and Risk of Breast Cancer Recurrence in Chinese Patients
This study provides real-world evidence from an Asian cohort supporting a possible role of aspirin in reducing breast cancer recurrence risk.
Authors
- X Wang (ORCID: https://orcid.org/0000-0002-1584-3225)
- Ruixian Chen (ORCID: https://orcid.org/0000-0002-5347-7094)
- Xin Zhao (ORCID: https://orcid.org/0000-0002-8178-4737)
- Yunhao Wu (ORCID: https://orcid.org/0000-0003-2435-0585)
- Weijing Liu (ORCID: https://orcid.org/0000-0001-9654-6208)
- Xiwen Yang
- Jie Chen (ORCID: https://orcid.org/0009-0002-3643-4866)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sichuan University (CN)
- Peking Union Medical College Hospital (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-0842
- Primary Topic
- Inflammatory mediators and NSAID effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00